Who has invested in Latigo Biotherapeutics?

Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures are named among the investors backing Latigo Biotherapeutics.

Latigo Biotherapeutics Funding: $135M Raised, Series A

Latigo Biotherapeutics funding overview

Latigo Biotherapeutics is a Biotech company based in Thousand Oaks, California. Latigo Biotherapeutics has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2024. The round record for Latigo Biotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures. 4 distinct backers are named across the disclosed rounds.

Latigo Biotherapeutics at a glance

Total raised: $135M
Latest round: Series A
Latest round date: February 2024
Industry: Biotech
Headquarters: Thousand Oaks, California
Notable investors: Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures

Frequently asked about Latigo Biotherapeutics funding

How much has Latigo Biotherapeutics raised?: Latigo Biotherapeutics has raised $135M in total disclosed funding across the rounds on record.
Who has invested in Latigo Biotherapeutics?: Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures are named among the investors backing Latigo Biotherapeutics.
What was the latest Latigo Biotherapeutics funding round?: The most recent disclosed round is a Series A, announced in February 2024.
Where is Latigo Biotherapeutics based?: Latigo Biotherapeutics is based in Thousand Oaks, California.
What sector does Latigo Biotherapeutics operate in?: Latigo Biotherapeutics is tracked under Biotech from Thousand Oaks, California, with $135M in disclosed funding.
When did Latigo Biotherapeutics last raise?: The last disclosed Latigo Biotherapeutics round closed in February 2024 at Series A.

Latigo Biotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Thousand Oaks below to benchmark round size and investor mix.

Latigo Biotherapeutics Funding: $135M Raised, Series A

Latigo Biotherapeutics funding overview

Latigo Biotherapeutics at a glance

Frequently asked about Latigo Biotherapeutics funding

Companies related to Latigo Biotherapeutics (35)

Browse related funding lists (7)